逆境诱导型启动子rd29A的克隆及植物表达载体的构建

根据文献上发表的逆境诱导型启动子rd29A序列设计并合成了一对引物,通过PCR的方法从拟南芥基因组中扩增到rd29A的启动子序列.根据GenBank中已发表的转录因子DREB1A基因的cDNA序列设计并合成了一对引物,通过RT-PCR的方法从低温处理的拟南芥总RNA中扩增出DREB1A基因的全长cDNA片段.以植物表达载体pBch为基础,构建了由rd29A调控的DREB1A基因的植物表达载体pBDR29A,为利用DREB1A基因改良植物抗逆性奠定了物质基础.     

T载体介导的基于attL核心区LR反应的简化快速Gateway克隆系统

Gateway克隆技术已得到广泛的应用。该技术先通过BP反应将目标片段连到带有完整attL特异识别位点的入门载体,然后与终载体通过LR反应得到表达载体。Gateway克隆方法与传统的酶切连接方法相比有快速简单等优点。但是,BP和LR酶都非常昂贵。本研究首先对3个常用Gateway载体的atts特异位点序列比对发现,attL序列核心交换位点“core attL”的21~22 bp长的碱基是保守和必要的。由此,设计含有core-attL序列的引物,通过PCR克隆得到DNA片段并连入pMD18-T载体,然后进行LR反应,可成功得到目标表达载体,并在保守的位点上正确重组。本研究还对其中一个带有绿色荧光蛋白基因的表达载体转化至烟草,能够正常表达该蛋白质。结果表明,通过将含有attL核心位点基因片段连接到pMD18-T载体上,可以省略BP反应而将目标片段连接到终载体上,节约了反应时间和成本。     

T载体介导的基于attL核心区LR反应的简化快速Gateway克隆系统（英文）

Gateway克隆技术已得到广泛的应用。该技术先通过BP反应将目标片段连到带有完整attL特异识别位点的入门载体,然后与终载体通过LR反应得到表达载体。Gateway克隆方法与传统的酶切连接方法相比有快速简单等优点。但是,BP和LR酶都非常昂贵。本研究首先对3个常用Gateway载体的atts特异位点序列比对发现,attL序列核心交换位点"core attL"的21~22 bp长的碱基是保守和必要的。由此,设计含有core-attL序列的引物,通过PCR克隆得到DNA片段并连入p MD18-T载体,然后进行LR反应,可成功得到目标表达载体,并在保守的位点上正确重组。本研究还对其中一个带有绿色荧光蛋白基因的表达载体转化至烟草,能够正常表达该蛋白质。结果表明,通过将含有attL核心位点基因片段连接到p MD18-T载体上,可以省略BP反应而将目标片段连接到终载体上,节约了反应时间和成本。     

以木糖异构酶基因xylA为选择标记的Gateway系统植物表达载体的构建

目的:构建以木糖异构酶基因xylA为筛选标记的无抗生素标记Gateway系统植物表达载体。方法:克隆大肠杆菌木糖异构酶基因xylA并用其替换植物表达载体pCAMBIA1301中的hpt基因,利用载体中的多克隆位点将Gateway Binary Vector(pH7WG2D)中酶切位点XbaⅠ和HindⅢ之间包括P35S、T35S、attR1、attR2和CmR-ccdB的片段重组入表达载体pCAMBIA1301中,构建表达载体pCAMBIA1301-xylA-GW,利用含有津田芜菁HY5基因片段的BP反应产物与载体进行LR反应,获得含有目的基因的植物表达载体pCAMBIA1301-xylA-HY5,并导入根癌农杆菌LBA4404中。结果:抗生素筛选及酶切和PCR鉴定表明成功构建了以xylA为筛选标记的无抗生素标记植物表达载体pCAMBIA1301-xylA-HY5。结论:利用木糖异构酶基因xylA结合Gateway克隆技术构建无抗生素标记植物表达载体,可简化、方便植物转基因表达载体构建。     

转录因子DREB1A基因的克隆与植物表达载体的构建

根据GenBank 中已发表的转录因子DREB1A基因的cDNA序列设计并合成了一对引物,通过RT-PCR的方法从低温处理的拟南芥总RNA中扩增出DREB1A基因的全长cDNA片段.将其克隆到 pMD18 T-vector中.经测序证明该片段与GenBank上报道的序列具有99.8%的同源性.2个碱基的置换导致了一处氨基酸的差异,但这一氨基酸并不在基因的功能结构域上,推测其不会影响基因功能.以植物表达载体pBch为基础,构建了由组成型启动子35S调控的DREB1A基因的植物表达载体pBDR35S,为利用DREB1A基因改良植物抗逆性奠定了物质基础.     

布鲁菌抗原的快速克隆与高效表达

目的:通过Gateway技术构建布鲁菌抗原表达载体,并筛选出高效可溶性表达载体。方法:以山羊布鲁菌16M株染色体DNA为模板,扩增4个布鲁菌抗原基因BMEI2002、BMEI1069、BMEI1483和BMEI0748,利用GatewayBP反应将基因克隆到入门载体pDONR201中,构建重组质粒,然后用Gateway LR反应将基因重组到3种表达载体(pDEST17、pHXGWA、pHGGWA)中,构建相应的重组表达质粒,将重组质粒转化大肠杆菌ER2566(DE3)并诱导表达,分析利用3个不同载体所表达蛋白的表达量及表达形式。结果:利用BP反应构建了4个基因的重组质粒,用LR反应将这些基因分别克隆到表达载体,构建得到了相应的表达载体;诱导表达后的可溶性分析显示,含6×His和TRX标签的pHXGWA所表达的蛋白在表达量和可溶性方面均优于pDEST17和pHGGWA。结论:通过Gateway技术实现了布鲁菌抗原的快速克隆,筛选到的pHXGWA可作为后续大规模克隆表达载体,为布鲁菌抗原的大规模克隆表达和保护性抗原的筛选奠定了基础。     

通路克隆入门载体pEN-L4~*-PrbcS-~*T-gfp-L3~*的构建及其应用

为了利用通路克隆(Gateway)技术构建一个含有两个目的基因表达盒的植物表达载体,并把目的基因编码的蛋白质定位到转基因植物的叶绿体中,通过定点突变技术,在含有attL4和attL3重组位点的Gateway入门载体pEN-L4-2-L3中产生HindⅢ和XhoⅠ的酶切位点,然后在这两个酶切位点之间插入一个含有1,5-二磷酸核酮糖羧化酶小亚基的光诱导型启动子(PrbcS)及其叶绿体基质定位序列(*T)和绿色荧光蛋白(GFP)报告基因(gfp)的DNA片段,获得pEN-L4*-PrbcS-*T-gfp-L3*入门载体.用该载体和另一个含有attL1和attL2重组位点的入门载体(pENTR*-PrbcS-*T-gus)与Gateway的目的载体pK7 m34GW2-8 m21GW3进行LR重组反应可以构建一个能串联gfp和gus两个报告基因表达盒的植物表达载体pKm-35S-PrbcS-*T-gfp-PROLD-PrbcS-*T-gus,所构建的植物表达载体转化烟草后,gfp和gus基因能插入到转基因烟草的基因组中并正常表达,所表达的GFP蛋白可正确定位到转基因植物的叶绿体中,而GUS蛋白也可以在叶片中表达.利用此表达载体通过一次转化事件不仅可以完成两个目的基因的转化操作,而且还可以利用叶绿体基质定位序列(*T)把PrbcS控制表达的目的蛋白直接定位到转基因植物的叶绿体中.因此pEN-L4*-PrbcS-*T-gfp-L3*入门载体的应用进一步扩大了Gateway技术及植物表达载体的应用范围,为叶绿体基因工程操作提供了一个更方便的技术平台.     

DREB1A 转录因子蛋白的原核表达

DREB1A是DREB转录因子的一员,它们都含有一段与DNA结合的保守区域,由58个氨基酸组成,称为EREBP/AP2结构域(EREBP/AP2 domain)。一个DREB转录因子可以调控多个与植物干旱、高盐及低温耐性有关的功能基因表达。从拟南芥中克隆了DREB1A转录因子基因,成功构建了DREB1A基因的原核表达载体,转化E.coliBL21(DE3),经1 mmol/L IPTG诱导表达获得了DREB1A蛋白,但以包涵体形式存在。为以后深入研究DREB转录因子与DRE顺式作用元件相互作用的具体机制奠定了基础。     

Prd29A及DREB1A的克隆和干旱诱导型植物表达载体的构建与鉴定

从拟南芥中克隆了RD29A基因的启动子(Prd29A)及DREB1M基因的DNA片段,构建Prd29A:DREB1A融合基因,采用合成的接头将该融合基因插入到植物表达载体pBI121中,经鉴定,确认正确.     

使用与Gateway技术兼容的T载体获得入门克隆

与Gateway技术兼容的农杆菌双元载体系统已开始应用于植物功能基因组的研究,但应用这些载体系统的一个瓶颈问题,是如何简单、经济和高效地将PCR产物或其他来源的目的DNA片段构建到入门载体上获得入门克隆.为此,将传统的TA克隆技术与Gateway重组克隆技术进行整合,构建了与Gateway技术兼容的两种TA克隆载体,用于在克隆PCR产物或其他来源的目的DNA片段的同时获得入门克隆.利用兼容Gateway技术的TA克隆载体有效地解决了上述瓶颈问题.     

An in vitro recombination method to convert restriction- and ligation-independent expression vectors

In recent years, restriction-less recombination cloning systems based on site-specific recombinase with high efficiency have been proven to be very successful. Thus, it is desirable to convert existing conventional vectors to recombination vectors. In this report, we describe the conversion of a set of widely used conventional vectors to Gateway recombination expression vectors. An attB cassette flanked by several restriction enzyme sites was inserted in a cloning vector, and then subcloned into existing vectors to be converted to construct intermediate vectors containing the attB cassette, which were then converted to recombination expression vectors by in vitro recombination. The intermediate vectors generated in this study can be used for releasing the attB cassette to convert other vectors using the same protocol described here. With the increasing number of recombination vectors constructed with this protocol, the likeliness of releasing the attB cassette from an existing vector, rather than synthesizing it with PCR, will increase. The final expression vectors can also be used for releasing the attR cassette for constructing new vectors.     

Lambda Chops: Creation of Site-Directed Mutants in Insertable Fragments Utilizing Gateway<Superscript>®</Superscript> Technology

We describe a method to produce site-directed mutations anywhere within cDNA by assembling mutagenized PCR fragments in proper orientation using lambda integration in an extension of Gateway technology to yield a full-length mutated gene. This process exploits the directionality of lambda insertion sequences ensuring integration and directionality of PCR product into a cloning vector. The process requires only two sequential integration steps to yield a mutagenized expression vector. Mutagenized vasodilator associated phosphoprotein (VASP) was produced by generating two PCR fragments representing the upstream and downstream portions of the gene, substituting alanine or glutamate residues for VASP serine239. The upstream PCR was engineered with attB1 lambda integration sequences at the 5′ region and attB2 at the 3′ region of the downstream fragment to ensure correct orientation. The desired mutation was encoded by the forward primer of fragment 2. The reverse primer of the fragment 1 was phosphorylated for subsequent ligation. Vent polymerase provided sequence accuracy and blunt-ended product. The first integration into a donor vector, catalyzed by BP Clonase II created a linear product circularized by blunt end ligation, yielding hundreds of entry vectors containing the mutagenized VASP. A second integration into destination vector yielded plasmid expressing mutant VASP upon transfection.     

几种新型植物基因表达载体的构建方法

利用基因工程技术手段研究基因功能过程中,构建基因表达载体处于转基因植物的主导地位,采用合适的构建方法会使实验效果事半功倍。植物基因表达载体的构建方法除了传统构建法、Gateway技术、三段T-DNA法、一步克隆法等,还有近年来出现的几种新型的载体构建方法:基于竞争性连接原理快速构建小片段基因表达载体;MicroRNA前体PCR置换法适用于构建小分子RNA表达载体;重组融合PCR法特别适用于插入片段中含有较多限制性酶切位点的载体构建;利用In-Fusion试剂盒可以将任何目的片段插入一个线性化载体的某个区域;构建多片段复杂载体可采用不依赖序列和连接的克隆方法(Sequence and ligation-independent cloning,SLIC)法;Gibson等温拼接法;Golden Gate拼接法。本文将在总结分析前人工作的基础上,结合自己工作的体会和经验分析这7种新方法的特点,期望通过这几种新的方法给植物基因工程表达载体的构建提供新的思路。     

Evidence for high specificity and efficiency of multiple recombination signals in mixed DNA cloning by the Multisite Gateway system

Six types of recombination signal DNA sequences of the Multisite Gateway cloning system were investigated as to their specificity and efficiency in the LR and BP recombination reactions. In the LR reaction to generate an Expression clone by recombination between attL and attR signals which are contained in the Entry clone and the Destination vector, respectively, the cross-reactivity of various attL and attR pairs on six types of respective signal sequences was examined. In the BP reaction to create an Entry clone by transferring the target DNA segment in the Expression clone or the attB-flanked PCR product into a Donor vector, various combinations of attB and attP pairs were tested for their reactivities in recombination. The results obtained indicate a markedly higher specificity and efficiency of cross-reactivity with only the matched att signal pairs, such as attL3-attR3, attB5-attP5, and so on, compared to unmatched signal pairs, such as attL3-attR5, attB5-attP3, and so on, thus verifying a high-throughput production of the positive clones in the Gateway system in which multiple recombination signals exist together in one reaction system. Examples of rapid construction of a three or four DNA-fusion structure in the plasmid are shown.     

High efficiency single step production of expression plasmids from cDNA clones using the Flexi Vector cloning system

The success of structural genomics and proteomics initiatives is dependent on the availability of target genes in vectors suitable for protein production. Here, we compare two high-throughput methods for producing expression vectors from plasmid-derived cDNA fragments. Expression vectors were constructed for compatibility with the Gateway recombination cloning system and the Flexi Vector restriction-based cloning system. Cloning protocols for each system were conducted in parallel for 96 different target genes from PCR through the production of sequence-verified expression clones. The short nucleotide sequences required to prepare the target open reading frames for Flexi Vector cloning allowed a single-step PCR protocol, resulting in fewer mutations relative to the Gateway protocol. Furthermore, through initial cloning of the target open reading frames directly into an expression vector, the Flexi Vector system gave time and cost savings compared to the protocol required for the Gateway system. Within the Flexi Vector system, genes were transferred between four different expression vectors. The efficiency of gene transfer between Flexi Vectors depended on including a region of sequence identity adjacent to one of the restriction sites. With the proper construction in the flanking sequence of the vector, gene transfer efficiencies of 95-98% were demonstrated.     

重组阳离子抗肿瘤肽AIK的原核表达、纯化及活性测定

利用Gateway克隆技术构建重组抗瘤肽AIK的原核表达体系,建立表达及纯化重组AIK的最优条件,为深入研究和利用AIK奠定基础。首先,设计含AttB重组位点的引物,通过重叠PCR技术扩增出Att B-TEV-FLAG-AIK序列,利用BP重组反应将目的序列TEV-FLAG-AIK克隆到供体载体pDONR223中,构建入门载体,再通过LR重组反应,将目的序列转移到目的载体pDEST15中,构建GST-AIK融合蛋白原核表达质粒。随后,在BL21(DE3)工程菌中优化诱导融合蛋白表达的条件。以谷胱甘肽磁珠纯化GST-AIK融合蛋白,再以rTEV酶切除GST,获得FLAG-AIK重组蛋白。最后以MTS法检测FLAG-AIK对白血病细胞HL-60的细胞毒性。菌液PCR验证和测序分析表明成功构建了重组抗瘤肽AIK的入门质粒和原核表达质粒。在BL21(DE3)工程菌中实现了GST-AIK融合蛋白的高效可溶性表达。并测得在37℃下以0.1 mmol/L IPTG诱导工程菌(OD600=1.0)4 h,重组蛋白表达量占菌体总蛋白的30%以上。经GST亲和层析、rTEV酶切除GST标签及二次GST亲和层析获得纯度高于95%的FLAG-AIK蛋白。MTS法测得所制备的FLAG-AIK蛋白抑瘤活性与化学合成的AIK相当。总之,本课题应用Gateway克隆系统成功构建了抗瘤肽AIK的原核表达质粒,实现了GST-AIK融合蛋白的高效可溶性表达,经亲和层析获得了有生物活性的重组AIK多肽,为后续深入研究和大规模制备奠定了基础。